BR112013027685A2 - composição oral líquida compreendendo divalproex sódico e processo de preparação do mesmo - Google Patents

composição oral líquida compreendendo divalproex sódico e processo de preparação do mesmo

Info

Publication number
BR112013027685A2
BR112013027685A2 BR112013027685A BR112013027685A BR112013027685A2 BR 112013027685 A2 BR112013027685 A2 BR 112013027685A2 BR 112013027685 A BR112013027685 A BR 112013027685A BR 112013027685 A BR112013027685 A BR 112013027685A BR 112013027685 A2 BR112013027685 A2 BR 112013027685A2
Authority
BR
Brazil
Prior art keywords
divalproex sodium
oral composition
liquid oral
preparing same
preparing
Prior art date
Application number
BR112013027685A
Other languages
English (en)
Inventor
Grover Manish
Jathar Shripad
Patil Prasad
Phadtare Ganesh Narayan
Sahana Dipak
Original Assignee
Abbott Healthcare Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46939730&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013027685(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Healthcare Private Ltd filed Critical Abbott Healthcare Private Ltd
Publication of BR112013027685A2 publication Critical patent/BR112013027685A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

resumo “composição oral líquida compreendendo divalproex sódico e processo de preparação do mesmo” refere-se a invenção de composição líquida oral palatável compreendendo divalproex sódico em uma composição oral líquida estável, sob a forma de solução, emulsão ou suspensão, compreendendo divalproex sódico e um ou mais excipientes farmaceuticamente aceitáveis selecionado a partir do grupo consistindo em conservantes, sabores, flavorizantes, edulcorantes, agentes tamponantes, agentes corantes e misturas dos mesmos e o processo para preparação do mesmo.
BR112013027685A 2011-05-02 2012-04-26 composição oral líquida compreendendo divalproex sódico e processo de preparação do mesmo BR112013027685A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1365MU2011 2011-05-02
PCT/IN2012/000307 WO2012150607A2 (en) 2011-05-02 2012-04-26 Oral liquid composition comprising divalproex sodium and process for preparing thereof

Publications (1)

Publication Number Publication Date
BR112013027685A2 true BR112013027685A2 (pt) 2016-12-27

Family

ID=46939730

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013027685A BR112013027685A2 (pt) 2011-05-02 2012-04-26 composição oral líquida compreendendo divalproex sódico e processo de preparação do mesmo

Country Status (6)

Country Link
BR (1) BR112013027685A2 (pt)
CL (1) CL2013003137A1 (pt)
CO (1) CO6801771A2 (pt)
EC (1) ECSP13013043A (pt)
MX (1) MX2013012827A (pt)
WO (1) WO2012150607A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104248627A (zh) * 2013-06-25 2014-12-31 北大方正集团有限公司 丙戊酸半钠泡腾干混悬剂及其制备方法
BE1026024B1 (nl) * 2018-02-16 2019-09-16 Neogen Nv Werkwijze voor het bereiden van een oplossing omvattende valproïnezuur en/of een of meerdere van zijn zouten, genoemde oplossing en gebruik
US11918675B2 (en) 2019-12-16 2024-03-05 Colgate-Palmolive Company Oral care compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009897A (en) 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
FR2643556B1 (fr) 1989-02-27 1993-03-05 Sanofi Sa Composition pharmaceutique a liberation prolongee d'acide valproique
US6528090B2 (en) 1998-12-18 2003-03-04 Abbott Laboratories Controlled release formulation of divalproex sodium
US6511678B2 (en) 1998-12-18 2003-01-28 Abbott Laboratories Controlled release formulation of divalproex sodium
US6419953B1 (en) 1998-12-18 2002-07-16 Abbott Laboratories Controlled release formulation of divalproex sodium
US6713086B2 (en) 1998-12-18 2004-03-30 Abbott Laboratories Controlled release formulation of divalproex sodium
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
US20110015267A1 (en) * 2009-07-20 2011-01-20 Deanna Jean Nelson Methods for the preparation and use of aqueous solutions of magnesium valproate hydrate and l-carnitine

Also Published As

Publication number Publication date
MX2013012827A (es) 2014-02-11
CO6801771A2 (es) 2013-11-29
ECSP13013043A (es) 2014-01-31
WO2012150607A2 (en) 2012-11-08
CL2013003137A1 (es) 2014-08-01
WO2012150607A3 (en) 2013-02-14

Similar Documents

Publication Publication Date Title
CY1123945T1 (el) Στοματικα σκευασματα αμεσης απελευθερωσης για υποκατεστημενες κιναζολινονες
CY1120429T1 (el) Παραγωγα κιναζολινης για τη θεραπευτικη αντιμετωπιση ιογενων λοιμωξεων και αλλων νοσων
RU2018114447A (ru) Введение дейтерированных усилителей cftr
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
BR112013027028A2 (pt) preparo de gadobutrol de alta pureza
BR112015020389A8 (pt) compostos carbazol úteis como inibidores de bromodomínio, seu uso, bem como composição e produto farmacêuticos compreendendo os mesmos
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
JP2014515038A5 (pt)
BR112014009910A2 (pt) formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
EA201692443A1 (ru) Водная фармацевтическая композиция тапентадола для перорального введения
BR112014005134A2 (pt) composição farmacêutica de dissolução rápida
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
MX2010003923A (es) Formulacion farmaceutica de valsartan.
EA201490653A1 (ru) Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств
WO2012035480A3 (en) Pharmaceutical compositions of curcumin
BR112014028069A2 (pt) composição farmacêutica oftálmica, processo para a preparação de uma composição farmacêutica oftálmica, uso de uma composição farmacêutica oftálmica, e, método para a prevenção ou tratamento de uma infecção fúngica
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
EA201400064A1 (ru) Офтальмологическая фармацевтическая композиция для местного применения, которая содержит регорафениб
BR112013027685A2 (pt) composição oral líquida compreendendo divalproex sódico e processo de preparação do mesmo
JP2015504860A5 (pt)
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção
BR112017025527A2 (pt) preparação farmacêutica líquida, e, método para fabricar uma suspensão de celocoxibe.
EA201490363A1 (ru) Новые составы на основе (триметоксифениламино)пиримидинилов

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements